Lai Wei
Impact in
Papers in
- Co-authors
- Tanios Bekaii‐Saab (25 shared papers)Michael Vinzenz Knopp (16 shared papers)Mario Ammirati (3 shared papers)Manisha H. Shah (11 shared papers)Lawrence M. Pfeffer (8 shared papers)John C. Byrd (10 shared papers)Zaibo Li (13 shared papers)Matthew David Ringel (3 shared papers)
- Journals
- Blood (10 papers)Cancer Immunology Immunotherapy (8 papers)Journal of the National Comprehensive Cancer Network (7 papers)Investigational New Drugs (5 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Lai Wei
236 papers receiving 6.6k citations
Lai Wei's Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 1.2k
- Genetics 475
- Endocrinology, Diabetes and Metabolism 911
- Immunology 534
- Otorhinolaryngology 122
Countries citing papers authored by Lai Wei
This map shows the geographic impact of Lai Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai Wei more than expected).
Fields of papers citing papers by Lai Wei
This network shows the impact of papers produced by Lai Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai Wei. The network helps show where Lai Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lai Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 483 | |
| 2 | Phase II Trial of Sorafenib in Metastatic Thyroid Cancer Hit paper breakdown → | 2009 | 454 |
| 3 | 2010 | 324 | |
| 4 | 2012 | 233 | |
| 5 | 2010 | 181 | |
| 6 | 2011 | 162 | |
| 7 | 2010 | 136 | |
| 8 | 2007 | 126 | |
| 9 | 2018 | 123 | |
| 10 | 2014 | 118 | |
| 11 | 2014 | 111 | |
| 12 | 2012 | 103 | |
| 13 | 2006 | 100 | |
| 14 | 2009 | 93 | |
| 15 | 2014 | 92 | |
| 16 | 2017 | 86 | |
| 17 | 2021 | 83 | |
| 18 | 2022 | 74 | |
| 19 | 2017 | 73 | |
| 20 | 2015 | 69 |
About Lai Wei
Lai Wei is a scholar working on Oncology, Genetics, Hepatology, Surgery and Pathology and Forensic Medicine, having authored 251 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Lymphoma Diagnosis and Treatment (10 papers), Gastroesophageal reflux and treatments (8 papers), interferon and immune responses (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Organ Transplantation Techniques and Outcomes (8 papers), Neuroendocrine Tumor Research Advances (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). The work is most often cited by research in Oncology (1.2k citations), Genetics (475 citations), Endocrinology, Diabetes and Metabolism (911 citations), Immunology (534 citations) and Otorhinolaryngology (122 citations). Lai Wei has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Tanios Bekaii‐Saab, Michael Vinzenz Knopp, Mario Ammirati, Manisha H. Shah, Lawrence M. Pfeffer, John C. Byrd, Zaibo Li, Matthew David Ringel, Joseph M. Flynn and Robert A. Fox. Their work appears in journals such as Blood, Cancer Immunology Immunotherapy, Journal of the National Comprehensive Cancer Network, Investigational New Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.